• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Founder-led biotech is making space for ideas—and diverse leaders—where it didn't...

cafead

Administrator
Staff member
  • cafead   Nov 23, 2021 at 10:32: AM
via Reshma Shetty, Ph.D., didn’t have a million dollars in her pocket when she came out of MIT with a graduate degree in biological engineering. She didn’t have a big-name backer or wealthy parents. But she did have a great idea and a mentor who encouraged her to go out and build her company from the ground up.

That idea became Ginkgo Bioworks, a biotech that aims to program cells just like we do computers. The company’s platform has applications across food and agriculture along with industrial chemicals and pharmaceuticals, and it counts Moderna and Roche as collaborators.

article source